For the first time, researchers had a tool that could stimulate GH without confounding hormonal changes allowing cleaner experimental designs and more interpretable results
Salven P, Lymboussaki A, Heikkil P, Jskela-Saari H, Enholm B, Aase K, et al
In this trial, liragutide treated patients not only did not benefit from the therapy, but also had a higher risk of developing arrhythmia and acute coronary syndrome compared to placebo (63)
has voiced support for expanding access to certain peptide therapies, while FDA reviewers have raised concerns about the limited evidence supporting the safety and effectiveness of the seven substances under consideration
Reduce the appearance of dryness and fine lines